In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 13, 2012, Pages 5040-5045

  Villenave, Rémi ^a   Thavagnanam, Surendran ^a,b   Sarlang, Severine ^a   Parker, Jeremy ^c   Douglas, Isobel ^b   Skibinski, Grzegorz ^a   Heaney, Liam G ^a   McKaigue, James P ^b   Coyle, Peter V ^c   Shields, Michael D ^a,b   Power, Ultan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL BELFAST HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Lung epithelium model; Primary airway epithelial cells; Virus host interaction

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 5; INTERLEUKIN 8; RANTES; RESPIRATORY SYNCYTIAL VIRUS VACCINE;

APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CELL DIFFERENTIATION; CELL HYPERPLASIA; CHILD; CILIATED EPITHELIUM; CONTROLLED STUDY; CYTOPATHOLOGY; EX VIVO STUDY; GOBLET CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SYNCYTIUM; VIRUS ISOLATION;

APOPTOSIS; BRONCHI; CELL DIFFERENTIATION; CHEMOKINES; CHILD; CILIA; CYTOPATHOGENIC EFFECT, VIRAL; EPITHELIAL CELLS; GIANT CELLS; GOBLET CELLS; HUMANS; HYPERPLASIA; MODELS, BIOLOGICAL; MUCUS; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84859452124     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1110203109     Document Type: Article

References (43)

1. Glezen WP, Taber LH, Frank AL, Kasel JA (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140:543-546. (Pubitemid 16120909)
2. Hall CB (2001) Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344:1917-1928.
3. Stein RT, et al. (1999) Respiratory syncytial virus inearly life and risk of wheeze and allergy by age 13 years. Lancet 354:541-545. (Pubitemid 29381367)
4. Sigurs N, et al. (2005) Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 171:137-141. (Pubitemid 40105412)
5. McNamara PS, Flanagan BF, Hart CA, Smyth RL (2005) Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 191:1225-1232.
6. Sheeran P, et al. (1999) Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 18:115-122. (Pubitemid 29101883)
7. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS (2007) The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 20:108-119. (Pubitemid 44967956)
8. Kurlandsky LE, French G, Webb PM, Porter DD (1988) Fatal respiratory syncytial virus pneumonitis in a previously healthy child. Am Rev Respir Dis 138:468-472.
9. Aherne W, Bird T, Court SD, Gardner PS, McQuillin J (1970) Pathological changes invirus infections of the lower respiratory tract in children. J Clin Pathol 23:7-18.
10. Welliver TP, et al. (2007) Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195:1126-1136. (Pubitemid 46543443)
11. Downham MA, Gardner PS, McQuillin J, Ferris JA (1975) Role of respiratory viruses in childhood mortality. BMJ 1:235-239.
12. Lugo RA, Nahata MC (1993) Pathogenesis and treatment of bronchiolitis. Clin Pharm 12:95-116.
13. Neilson KA, Yunis EJ (1990) Demonstration of respiratory syncytial virus in an autopsy series. Pediatr Pathol 10:491-502. (Pubitemid 20356340)
14. Wright C, Oliver KC, Fenwick FI, Smith NM, Toms GL (1997) A monoclonal antibody pool for routine immunohistochemical detection of human respiratory syncytial virus antigens in formalin-fixed, paraffin-embedded tissue. J Pathol 182:238-244. (Pubitemid 27287848)
15. Chanock R, Roizman B, Myers R (1957) Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. Am J Hyg 66:281-290.
16. Gray TE, Guzman K, Davis CW, Abdullah LH, Nettesheim P (1996) Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am J Respir Cell Mol Biol 14:104-112. (Pubitemid 126443096)
17. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD (2004) Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA 101:4620-4624. (Pubitemid 38437460)
18. Zhang L, et al. (2005) Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 79:1113-1124. (Pubitemid 40053894)
19. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ (2002) Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 76:5654-5666. (Pubitemid 34517916)
20. Lopez-Souza N, et al. (2009) In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol 123:1384-1390.
21. Villenave R, et al. (2010) Cytopathogenesis of Sendai virus in well-differentiated primary pediatric bronchial epithelial cells. J Virol 84:11718-11728.
22. Oshansky CM, Krunkosky TM, Barber J, Jones LP, Tripp RA (2009) Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway. Viral Immunol 22:147-161.
23. Oshansky CM, Barber JP, Crabtree J, Tripp RA (2010) Respiratory syncytial virus Fand G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells. J Infect Dis 201:1201-1207.
24. Hall CB, Douglas RG, Jr., Simons RL, Geiman JM (1978) Interferon production inchildren with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr 93:28-32. (Pubitemid 8351863)
25. Melendi GA, et al. (2010) Breastfeeding is associated with the production of type I interferon in infants infected with influenza virus. Acta Paediatr 99:1517-1521.
26. Mellow TE, et al. (2004) The effect of respiratory synctial virus on chemokine release by differentiated airway epithelium. Exp Lung Res 30:43-57. (Pubitemid 38117525)
27. Wright PF, et al. (2005) Growth of respiratory syncytial virus in primary epithelial cells from the human respiratory tract. J Virol 79:8651-8654. (Pubitemid 40853565)
28. Henderson FW, Hu SC, Collier AM (1978) Pathogenesis of respiratory syncytial virus infection in ferret and fetal human tracheas in organ culture. Am Rev Respir Dis 118:29-37. (Pubitemid 8394390)
29. Hallak LK, Spillmann D, Collins PL, Peeples ME (2000) Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 74:10508-10513.
30. Villenave R, et al. (2011) Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells. Virol J 8:43.
31. Bourgeois C, Bour JB, Lidholt K, Gauthray C, Pothier P (1998) Heparin-like structures onrespiratory syncytial virus are involved in its infectivity in vitro. J Virol 72:7221-7227. (Pubitemid 28377851)
32. Luster AD, Unkeless JC, Ravetch JV (1985) Gamma-interferon transcriptionally regulates anearly-response gene containing homology to platelet proteins. Nature 315:672-676. (Pubitemid 15232881)
33. Okabayashi T, et al. (2011) Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res 160:360-366.
34. Wiley SR, et al. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682. (Pubitemid 26091143)
35. Bem RA, et al. (2009) Potential role of soluble TRAIL in epithelial injury in children with severe RSV infection. Am J Respir Cell Mol Biol 42:697-705.
36. Park JA, Tschumperlin DJ (2009) Chronic intermittent mechanical stress increases MUC5AC protein expression. Am J Respir Cell Mol Biol 41:459-466.
37. Thavagnanam S, et al. (2011) Effects of IL-13 on mucociliary differentiation of pediatric asthmatic bronchial epithelial cells. Pediatr Res 69:95-100.
38. Tamaoka M, et al. (2008) The epidermal growth factor receptor mediates allergic airway remodelling in the rat. Eur Respir J 32:1213-1223.
39. Kibe A, et al. (2003) Differential regulation byglucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am J Respir Crit Care Med 167:50-56. (Pubitemid 36015917)
40. Jones A, et al. (2002) Neutrophil survival isprolonged in the airways of healthy infants and infants with RSV bronchiolitis. Eur Respir J 20:651-657.
41. Yasui K, et al. (2005) Neutrophil-mediated inflammation inrespiratory syncytial viral bronchiolitis. Pediatr Int 47:190-195. (Pubitemid 40545424)
42. Doherty GM, et al. (2003) Non-bronchoscopic sampling and culture of bronchial epithelial cells in children. Clin Exp Allergy 33:1221-1225. (Pubitemid 37108525)
43. Parker J, et al. (2010) A 3-D well-differentiated model of pediatric bronchial epithelium demonstrates unstimulated morphological differences between asthmatic and nonasthmatic cells. Pediatr Res 67:17-22.